Newsfeeds - Spark Newswire

1 minute read

Prothena Corp Q4 EPS $0.12 Beats $(0.47) Estimate, Sales $49.92M Beat $29.14M Estimate

Today, 8:55 AM

Prothena Corp (NASDAQ:PRTA) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $(0.47) by 125.53 percent. This is a 116.9 percent increase over losses of $(0.71) per share from

PRTA

17 minute read

Earnings

Earnings Scheduled For February 23, 2023

By Benzinga Insights

Today, 8:55 AM

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

AAOI

1 minute read

Prothena Touts Encouraging Data From Early-Stage Alzheimer’s Candidate

By Vandana Singh

Today, 8:55 AM

Prothena Corporation plc (NASDAQ:PRTA) announced topline data from the Phase 1 single ascending dose (SAD) study for PRX005 for Alzheimer’s disease. …

BMY

1 minute read

Piper Sandler Initiates Coverage On Prothena Corp with Overweight Rating, Announces Price Target of $94

By Benzinga Newsdesk

Today, 8:55 AM

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Prothena Corp (NASDAQ:PRTA) with a Overweight rating and announces Price Target of $94.

PRTA

1 minute read

Analyst Ratings

Analyst Expectations for Prothena Corp’s Future

By Benzinga Insights

Today, 8:55 AM

Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

PRTA

1 minute read

Analyst Ratings

Cantor Fitzgerald Maintains Overweight Rating for Prothena Corp: Here’s What You Need To Know

By Benzinga Insights

Today, 8:55 AM

Cantor Fitzgerald has decided to maintain its Overweight rating of Prothena Corp (NASDAQ:PRTA) and raise its price target…

PRTA

2 minute read

Reported Late Wednesday, Prothena Announces Pricing Of $172.4M Public Offering Of 3.25M Shares At A Price Of $56.50/Share

By Benzinga Newsdesk

Today, 8:55 AM

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it priced an

PRTA

1 minute read

Why Prothena Shares Are Nosediving During Tuesday’s After-Hours Session

By Henry Khederian

Today, 8:55 AM

Prothena Corporation PLC (NASDAQ: PRTA) shares are trading lower by some 8.35% to $57.95 during Tuesday's after-hours session. The company announced that it has commenced an underwritten public offering of 3,000,000 of its ordinary shares. What Else?

PRTA

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 8:55 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABBV

1 minute read

RBC Capital Downgrades Prothena Corp to Sector Perform, Raises Price Target to $55

By Benzinga Newsdesk

Today, 8:55 AM

RBC Capital analyst Brian Abrahams downgrades Prothena Corp (NASDAQ:PRTA) from Outperform to Sector Perform and raises the price target from $52 to $55.

PRTA